Public @autismcrisis posts on Bluesky and Twitter/X

This page lists public posts integrated from @autismcrisis.bsky.social on Bluesky and archived posts from Twitter/X in one chronological feed. It supports reading, filtering and structured review of Michelle Dawson’s public posts used in the autism science watch project.

Twitter/X and Bluesky

14992 posts:

Post published on Twitter/X on 12 May 2021 10:59

Information about the link integrated into the post

DOI work

M. Zachary Rosenthal, Deepika Anand, Clair Robbins, Zachary J. Williams, Rachel Guetta, Jacqueline Trumbull, Lisalynn Kelly (2021). Development and Initial Validation of the Duke Misophonia Questionnaire. openRxiv.

Link to cited source
View post record

Post published on Twitter/X on 12 May 2021 03:28

Information about the link integrated into the post

Systematic review registry

(n.d.). PROSPERO. CRD/PROSPERO. Centre for Reviews and Dissemination, University of York.

Link to cited source
View post record

Post published on Twitter/X on 11 May 2021 11:37

Information about the link integrated into the post

DOI work

Joanne Halsall, Chris Clarke, Laura Crane (2021). “Camouflaging” by adolescent autistic girls who attend both mainstream and specialist resource classes: Perspectives of girls, their mothers and their educators. Autism, 25(7), 2074-2086. SAGE Publications.

Link to cited source
View post record

Post published on Twitter/X on 11 May 2021 10:49

Information about the link integrated into the post

DOI work

Edmund Sonuga-Barke, Anita Thapar (2021). The neurodiversity concept: is it helpful for clinicians and scientists?. The Lancet Psychiatry, 8(7), 559-561. Elsevier BV.

Link to cited source
View post record

Post published on Twitter/X on 11 May 2021 03:24

Information about the link integrated into the post

DOI work

Chantel Ritter, Katherine Hewitt, Carly A. McMorris (2021). Psychotropic Polypharmacy Among Children and Youth with Autism: A Systematic Review. Journal of Child and Adolescent Psychopharmacology, 31(4), 244-258. SAGE Publications.

Link to cited source
View post record

Post published on Twitter/X on 10 May 2021 13:41

Information about the link integrated into the post

DOI work

Daniela R. Junqueira, Rachel Phillips, Liliane Zorzela, Su Golder, Yoon Loke, David Moher, John P. A. Ioannidis, Sunita Vohra (2021). Time to improve the reporting of harms in randomized controlled trials. Journal of Clinical Epidemiology, 136, 216-220. Elsevier BV.

Link to cited source
View post record

Post published on Twitter/X on 10 May 2021 02:30

1 integrated reply by Michelle Dawson

10 May 2021 02:33

Note: among this trial's exclusion criteria for autistics was "Significant risk for suicidal behavior, in the opinion of the investigator"

View reply on Twitter/X

Information about the link integrated into the post

Clinical trial

Hoffmann-La Roche (2018). A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension. ClinicalTrials.gov. Hoffmann-La Roche.

Link to cited source
View post record

Post published on Twitter/X on 9 May 2021 14:01

Information about the link integrated into the post

DOI work

Jennifer R Spoor, Simon M Bury, Darren Hedley (2021). Non-autistic employees’ perspectives on the implementation of an autism employment programme. Autism, 25(8), 2177-2188. SAGE Publications.

Link to cited source
View post record